News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Impact Biomedical announces 1-for-12.62 reverse stock split effective Sept 23, 2026, to facilitate a planned merger with Zoar Limited.
  • Post-split Impact shareholders will receive one Zoar share for each Impact share held.
  • SB Energy plans to sell up to $500 million of new shares to Japanese investors ahead of a U.S. IPO.
  • Proceeds will fund development of data centers, power generation, and related infrastructure.
  • Prospectus confirms Nvidia commitments and warrants issued to OpenAI but does not disclose the planned IPO size.
  • Qualcomm's AWS pact lets AWS buy up to $60 billion in Qualcomm data-center chips and includes $4 billion in warrants.
  • Qualcomm stock rallied after the pact, boosting returns in AI-infrastructure-focused model portfolios.

Latest Articles

etoro to Acquire TradeZero to Accelerate US Expansion

etoro to Acquire TradeZero to Accelerate US Expansion

etoro Group Ltd. announced an agreement to acquire TradeZero, a US-based online brokerage for active traders, for up to $231 million in cash and shares. The deal will enhance etoro's US market presence by adding TradeZero's advanced trading platforms, broker-dealer infrastructure, and access to Canadian markets. The acquisition is expected to be ac…

Ridgepost Capital to Sponsor IPEM Global 2026

Ridgepost Capital to Sponsor IPEM Global 2026

Ridgepost Capital, a NYSE-listed private markets solutions provider managing over $50 billion in assets, announced its sponsorship at IPEM Global 2026 in Paris. Key executives and representatives from its investment strategies will attend to engage with peers and clients, highlighting the firm's capabilities in private equity, private credit, and v…

CVRx Announces Sales Leadership Transition

CVRx Announces Sales Leadership Transition

CVRx, Inc., a medical device company specializing in neuromodulation for cardiovascular diseases, announced a leadership change in its sales department. Robert John, the Chief Revenue Officer, is departing, and Paul Verrastro will serve as Interim Head of Sales while a search for a permanent replacement is underway. Verrastro brings over 30 years o…

Brazil’s Court of Appeal Perserves Rulings Favourable to the Autazes Potash Project, Blocks Referral of Appeals to Superior Courts

Brazil’s Court of Appeal Perserves Rulings Favourable to the Autazes Potash Project, Blocks Referral of Appeals to Superior Courts

Brazil Potash Corp. announced that Brazil's Federal Regional Court of the 1st Region reaffirmed the legitimacy of the consultation process with the Mura Indigenous people, upheld the authority of the Amazonas Environmental agency to license the Autazes potash project, and blocked appeals to higher courts. These rulings strengthen the legal foundati…

Beyond Meat Announces 1-for-30 Reverse Stock Split

Beyond Meat Announces 1-for-30 Reverse Stock Split

Beyond Meat announced a 1-for-30 reverse stock split of its common shares effective August 13, 2026, to meet Nasdaq minimum bid price requirements and maintain its Nasdaq Global Select Market listing. The split adjusts shares, authorized share counts, convertible notes, warrants, and equity awards proportionately, without changing shareholder owner…

AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD)

AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD)

AC Immune SA announced that the FDA granted Fast Track designation and approved its Investigational New Drug (IND) application for ACI-7104, an active immunotherapy targeting alpha-synuclein aggregates in early-stage Parkinson’s disease. Positive interim Phase 2 data demonstrated safety, tolerability, and immunogenicity, supporting further clinical…

Energence Utah Partnership Positions Senmiao to Pursue Digital Infrastructure Development, with 100 MW Targeted During the Initial Two-Year Development Phase

Energence Utah Partnership Positions Senmiao to Pursue Digital Infrastructure Development, with 100 MW Targeted During the Initial Two-Year Development Phase

Senmiao Technology Limited has announced a letter of intent to invest $5 million in Energence Utah, a planned digital infrastructure campus in Utah supported by energy project developer Elio Energy Group. The development aims to build a power-intensive data center campus with an initial target of 100 MW capacity within two years, scaling up to 1.2 …

Lithium Argentina Reports Second Quarter 2026 Results

Lithium Argentina Reports Second Quarter 2026 Results

Lithium Argentina AG announced robust second quarter 2026 results driven by strong performance at the Cauchari-Olaroz lithium brine operation in Argentina. The company generated over $141 million free cash flow from operations, reduced net debt by $114 million, and remains on track to meet full-year production guidance. Furthermore, Lithium Argenti…

Barrick Appoints Sebastiaan Bock CEO, Rest of World

Barrick Appoints Sebastiaan Bock CEO, Rest of World

Barrick Mining Corporation has named Sebastiaan Bock as CEO, Rest of World, overseeing its gold and copper portfolios outside North America, including operations across Africa, the Middle East, Latin America, and Asia Pacific. Bock's leadership experience aligns with Barrick's growth strategy to increase production by over 20% in the next three yea…